Solex Energy Q4 profit more than quadruples to ₹58 crore; revenue climbs 3.5X
On Saturday (May 15), shares of Solex Energy Ltd ended at ₹1,325.00, up by ₹74.00, or 5.92%, on the NSE.
Uncategorized
Rolex Rings Q4 Results: Revenue, EBITDA up 8% each; Margins flat
While the company reported a net loss this quarter, its revenue, EBITDA increased and margins remained unchanged.
Allcargo Terminals volumes rise 7% YoY in April to 59,200 TEUs
Total volumes for the month stood at 59.2 thousand TEUs, reflecting continued growth in container handling volumes on both a year-on-year and sequential basis.
Onesource Specialty Pharma gets government nod for Unit II expansion project
The company said Unit II is a flagship facility of the company and the proposed expansion represents a significant step in its growth strategy to enhance manufacturing capacities for servicing global partners.
Latent View Analytics Q4 Results | Net profit slips 1% despite 24% revenue growth
On Friday (May 15), shares of Latent View Analytics Ltd ended at ₹306.50, up by ₹16.25, or 5.60%, on the BSE.
Aurobindo Pharma arm gets CDSCO marketing nod for Bevqolva
Aurobindo Pharma said the Central Drugs Standard Control Organization (CDSCO) has granted marketing authorization under Form CT 23 for the bevacizumab biosimilar for metastatic carcinoma of the colon or rectum.
Amber Enterprises Q4 Results: Net profit and EBITDA rise, margins expand to 8.6%
Amber Enterprises reported a net profit of ₹134 crore above a CNBC-TV18 poll’s ₹129 crore. It was also 15.3% more than last year’s ₹116.07 crore.
AB Capital board to meet on May 20 to consider fund raise proposal via issue of shares, QIP, preferential issue
The company, in an exchange filing, said its board of directors is scheduled to meet on May 20 to consider the proposal of rasing funds via issuing equity shares or other securities of the firm through qualified institutional placement (QIP),…
Dr Reddy’s Laboratories launches generic semaglutide injection in Canada
Dr Reddy’s said it is among the first to introduce a generic semaglutide injection in the Canadian market after it received the Notice of Compliance (NOC) from Health Canada on April 28, 2026.
US stocks post worst day since March as bonds get hit
In the worst session for equities since March, the S&P 500 fell 1.2%. A gauge of chipmakers — which had led a surge from war-driven lows — sank 4%. US 10-year yields topped 4.5% while those on Japan’s 30-year debt…